parthenolide has been researched along with Angiogenesis, Pathologic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Brodowski, L; Meyer, N; Schröder-Heurich, B; von Kaisenberg, C; von Versen-Höynck, F | 1 |
| Kim, SL; Kim, SW; Lee, ST; Park, YR | 1 |
| Al Kury, LT; Talib, WH | 1 |
| Kim, DG; Kim, IH; Kim, SH; Kim, SL; Kim, SW; Lee, SO; Lee, ST; Trang, KT | 2 |
| Chen, Z; Kong, F; Li, Q; Tian, X; You, Y; Yu, K; Zhao, J; Zou, P | 1 |
| Nakabayashi, H; Shimizu, K | 1 |
| Bhat-Nakshatri, P; Cheng, L; DeGrado, T; Gokmen-Polar, Y; Hutchins, GD; Jayaprakasan, V; Kelich, S; Miller, KD; Miller, MA; Nakshatri, H; Shanmugam, R; Sledge, GW; Sweeney, CJ; Yip-Schneider, M; Zheng, QH | 1 |
8 other study(ies) available for parthenolide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Cyclosporine A and Tacrolimus Induce Functional Impairment and Inflammatory Reactions in Endothelial Progenitor Cells.
Topics: Cardiovascular Diseases; Cell Movement; Cell Proliferation; Chemotaxis; Cyclosporine; Cytokines; Endothelial Cells; Endothelial Progenitor Cells; Humans; Immunosuppressive Agents; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Neovascularization, Pathologic; NF-kappa B; NF-kappa B p50 Subunit; Sesquiterpenes; Signal Transduction; Stem Cells; Tacrolimus; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2021 |
Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
Topics: Animals; Cell Hypoxia; Colonic Neoplasms; Down-Regulation; Epithelial-Mesenchymal Transition; Female; HCT116 Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression.
Topics: A549 Cells; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neovascularization, Pathologic; Nicotine; Real-Time Polymerase Chain Reaction; Sesquiterpenes; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A | 2018 |
Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer.
Topics: Cell Movement; Cell Survival; Colorectal Neoplasms; HCT116 Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Pathologic; Receptors, Vascular Endothelial Growth Factor; Sesquiterpenes; Vascular Endothelial Growth Factor A | 2014 |
Inhibitory effects of parthenolide on the angiogenesis induced by human multiple myeloma cells and the mechanism.
Topics: Cell Line, Tumor; Endothelial Cells; Humans; Interleukin-6; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Multiple Myeloma; Neovascularization, Pathologic; NF-kappa B; RNA, Messenger; Sesquiterpenes; Umbilical Veins; Vascular Endothelial Growth Factor A | 2008 |
Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis.
Topics: Apoptosis; Carcinogenesis; Colorectal Neoplasms; Cytochromes c; Genes, bcl-2; HT29 Cells; Humans; Mitochondria; Neovascularization, Pathologic; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays | 2012 |
Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis Regulatory Proteins; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Signal Transduction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model.
Topics: Androgen Antagonists; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Bridged-Ring Compounds; Cell Line, Tumor; Docetaxel; Drug Synergism; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Nitriles; Prostatic Neoplasms; Radionuclide Imaging; Sesquiterpenes; Taxoids; TNF Receptor-Associated Factor 1; TNF Receptor-Associated Factor 2; Tosyl Compounds; Umbilical Veins; Vascular Endothelial Growth Factor A | 2006 |